News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Travere Therapeutics
NEWS
JOBS
IN THE PRESS
NEWS
Policy
More Trouble for Retrophin Founder
January 8, 2015
·
2 min read
Policy
Ex-Retrophin CEO Sold Stock While Urging Investors To Buy
November 26, 2014
·
2 min read
Business
Retrophin Booted CEO For Multiple Stock Violations: Report
October 3, 2014
·
2 min read
Biotech Bay
Retrophin, Inc., Gilead Sciences, Inc., And Our Healthcare Values
September 15, 2014
·
1 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 12, 2026
May 13, 2026
·
1 min read
Press Releases
Travere Therapeutics to Participate at Upcoming Investor Conferences - May 7, 2026
May 8, 2026
·
1 min read
Press Releases
Travere Prices Upsized $475.0 Million Convertible Senior Notes Offering to Refinance 2029 Convertible Notes
May 7, 2026
·
8 min read
Press Releases
Travere Announces Proposed Convertible Senior Notes Offering to Refinance 2029 Convertible Notes
May 6, 2026
·
6 min read
Press Releases
Travere Therapeutics Reports First Quarter 2026 Financial Results
May 5, 2026
·
19 min read
Press Releases
Travere Therapeutics to Report First Quarter 2026 Financial Results
April 28, 2026
·
1 min read
Press Releases
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 14, 2026
April 15, 2026
·
1 min read
Press Releases
Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan) in FSGS
April 14, 2026
·
8 min read
Press Releases
Travere Therapeutics Announces Full FDA Approval of FILSPARI® (sparsentan), the First and Only Approved Medicine for FSGS
April 14, 2026
·
19 min read
Press Releases
Travere Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
February 19, 2026
·
19 min read
